ATELLICA TM IM CYCLOSPORINE
Mexico·Clase I·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.·Registered June 14, 2018EL ENSAYO ATELLICA™ IM CYCLOSPORINE (CSA) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE CICLOSPORINA EN SANGRE COMPLETA HUMANA (EDTA).
THE ATELLICA™ IM CYCLOSPORINE ASSAY (CSA) IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF CYCLOSPORINE IN HUMAN WHOLE BLOOD (EDTA).
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE CICLOSPORINA
- Trade Name (English)
- CYCLOSPORINE ASSAY
- Analysis ID
- 1559R2018 SSA
- Registration Date
- June 14, 2018
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.
Access comprehensive regulatory information for ATELLICA TM IM CYCLOSPORINE (ATELLICA TM IM CYCLOSPORINE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1559R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 14, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.